文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

住院患者中的重症猴痘——美国,2022年8月10日至10月10日

Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2022-11-04

截至2022年10月21日,美国共报告27,884例猴痘病例。本报告总结了2022年8月10日至10月10日期间CDC为57例住院重症猴痘成人患者提供的临床会诊结果,其中47例(82%)合并HIV感染,17例(30%)接受ICU级别护理,12例(21%)死亡。

要点

  • 住院重症猴痘患者中82%合并HIV感染,多数为男性(95%)和非西班牙裔黑人(68%)。
  • 30%的患者需要ICU级别护理,21%死亡;猴痘是其中5例死亡的原因或促进因素。
  • providers应对所有有性活动的疑似猴痘患者进行HIV检测,除非已知HIV感染。

核心结论

  • 当前美国猴痘疫情中观察到与猴痘相关的重症发病和死亡,尤其是在高度免疫抑制人群中。

研究设计与样本

  • 本报告总结了2022年8月10日至10月10日期间CDC为57例年龄≥18岁、因重症猴痘表现住院的患者提供的临床会诊结果,并重点介绍了三例临床代表性病例。

主要发现

  • 47例(82%)患者合并HIV感染,其中4例(9%)在猴痘诊断前正在接受抗逆转录病毒治疗(ART)。
  • 大多数患者为男性(95%),68%为非西班牙裔黑人。
  • 17例(30%)患者接受了ICU级别护理,12例(21%)死亡。
  • 截至本报告,猴痘是其中5例死亡的原因或促进因素;6例死亡仍在调查中,以确定猴痘是否为因果或促进因素;1例死亡中猴痘不是原因或促进因素。

临床怎么用

  • 卫生保健提供者和公共卫生专业人员应意识到当前美国疫情中观察到与猴痘相关的重症发病和死亡,尤其是在高度免疫抑制人群中。
  • 提供者应在猴痘检测时对所有有性活动的疑似猴痘患者进行HIV检测,除非患者已知HIV感染。
  • 提供者应考虑对疑似或实验室诊断猴痘的高度免疫抑制患者早期开始并延长猴痘针对性治疗的疗程。
  • 让所有HIV感染者持续接受护理仍是关键的公共卫生优先事项。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As of October 21, 2022, a total of 27,884 monkeypox cases (confirmed and probable) have been reported in the United States.§ Gay, bisexual, and other men who have sex with men have constituted a majority of cases, and persons with HIV infection and those from racial and ethnic minority groups have been disproportionately affected (1,2). During previous monkeypox outbreaks, severe manifestations of disease and poor outcomes have been reported among persons with HIV infection, particularly those with AIDS (3-5). This report summarizes findings from CDC clinical consultations provided for 57 patients aged ≥18 years who were hospitalized with severe manifestations of monkeypox¶ during August 10-October 10, 2022, and highlights three clinically representative cases. Overall, 47 (82%) patients had HIV infection, four (9%) of whom were receiving antiretroviral therapy (ART) before monkeypox diagnosis. Most patients were male (95%) and 68% were non-Hispanic Black (Black). Overall, 17 (30%) patients received intensive care unit (ICU)-level care, and 12 (21%) have died. As of this report, monkeypox was a cause of death or contributing factor in five of these deaths; six deaths remain under investigation to determine whether monkeypox was a causal or contributing factor; and in one death, monkeypox was not a cause or contributing factor.** Health care providers and public health professionals should be aware that severe morbidity and mortality associated with monkeypox have been observed during the current outbreak in the United States (6,7), particularly among highly immunocompromised persons. Providers should test all sexually active patients with suspected monkeypox for HIV at the time of monkeypox testing unless a patient is already known to have HIV infection. Providers should consider early commencement and extended duration of monkeypox-directed therapy†† in highly immunocompromised patients with suspected or laboratory-diagnosed monkeypox.§§ Engaging all persons with HIV in sustained care remains a critical public health priority.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Miller MJ, Cash-Goldwasser S, Marx GE, et al. Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36327164. doi:10.15585/mmwr.mm7144e1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。